✦ LIBER ✦

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis

✍ Scribed by Adam R Topp

Book ID: 113696314
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 43 KB
Volume: 18
Category: Article
ISSN: 0883-9441
DOI: 10.1016/j.jcrc.2003.08.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of recombinant human

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis

✍ Robert A Fowler; Marya Hill-Popper; John Stasinos; Constantia Petrou; Gillian D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Use of recombinant human activated prote

Use of recombinant human activated protein C in patients with severe sepsis: a

✍ Laurent Muller; Samir Jaber; Alice Raillard; Jean Yves Lefrant 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 509 KB

Efficacy and Safety of Recombinant Human

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

✍ Bernard, Gordon R.; Vincent, Jean-Louis; Laterre, Pierre-Francois; LaRosa, Steve 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 564 KB

Activated protein C for the treatment of

Activated protein C for the treatment of severe sepsis

✍ G. Houston; B. H. Cuthbertson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PIN4 COST-EFFECTIVENESS OF DROTRECOGIN A

PIN4 COST-EFFECTIVENESS OF DROTRECOGIN ALFA (ACTIVATED) IN THE TREATMENT OF SEVERE SEPSIS IN SPAIN

✍ JA Sacristán; L Prieto; T Huete; A Artigas; X Badia; C Chinn; P Hudson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Cost-effectiveness of drotrecogin alfa (

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

✍ Aileen R Neilson; Hilmar Burchardi; Chris Chinn; Johannes Clouth; Heinz Schneide 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB